These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26409193)

  • 21. Preparation and characterization of self-assembled chitosan nanoparticles for the sustained delivery of streptokinase: an in vivo study.
    Modaresi SM; Ejtemaei Mehr S; Faramarzi MA; Esmaeilzadeh Gharehdaghi E; Azarnia M; Modarressi MH; Baharifar H; Vaez SJ; Amani A
    Pharm Dev Technol; 2014 Aug; 19(5):593-7. PubMed ID: 23859703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
    Leonardi D; Salomón CJ; Lamas MC; Olivieri AC
    Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
    Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
    J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent study of stability and cytotoxicity of a novel nanoemulsion system - an artificial neural networks approach.
    Seyedhassantehrani N; Karimi R; Tavoosidana G; Amani A
    Pharm Dev Technol; 2017 May; 22(3):383-389. PubMed ID: 27780386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs.
    Abdel-Hafez SM; Hathout RM; Sammour OA
    Int J Biol Macromol; 2014 Mar; 64():334-40. PubMed ID: 24355618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
    Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
    Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
    Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
    Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
    Douglas KL; Piccirillo CA; Tabrizian M
    J Control Release; 2006 Oct; 115(3):354-61. PubMed ID: 17045691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the genotoxicity of chitosan nanoparticles for use in food packaging films.
    De Lima R; Feitosa L; do Espírito Santo Pereira A; de Moura MR; Ahmad Aouada F; Henrique Capparelli Mattoso L; Fernandes Fraceto L
    J Food Sci; 2010 Aug; 75(6):N89-96. PubMed ID: 20722945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-engineering chitosan particles to sustain the release of promethazine from orodispersables.
    Elwerfalli AM; Al-Kinani A; Alany RG; ElShaer A
    Carbohydr Polym; 2015 Oct; 131():447-61. PubMed ID: 26256206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and characterization of chitosan-silver nanocomposite films and their antibacterial activity against Staphylococcus aureus.
    Regiel A; Irusta S; Kyzioł A; Arruebo M; Santamaria J
    Nanotechnology; 2013 Jan; 24(1):015101. PubMed ID: 23221018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
    Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliable size determination of nanoparticles using dynamic light scattering method for in vitro toxicology assessment.
    Kato H; Suzuki M; Fujita K; Horie M; Endoh S; Yoshida Y; Iwahashi H; Takahashi K; Nakamura A; Kinugasa S
    Toxicol In Vitro; 2009 Aug; 23(5):927-34. PubMed ID: 19397995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of biodegradable nanoparticles of tri-block PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial neural network.
    Asadi H; Rostamizadeh K; Salari D; Hamidi M
    J Microencapsul; 2011; 28(5):406-16. PubMed ID: 21736525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of glycyrrhetinic acid modification on preparation and evaluation of quercetin-loaded chitosan-based self-aggregates.
    Du H; Liu M; Yang X; Zhai G
    J Colloid Interface Sci; 2015 Dec; 460():87-96. PubMed ID: 26319324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery.
    Cheng Y; Cai H; Yin B; Yao P
    Int J Pharm; 2013 Sep; 454(1):425-34. PubMed ID: 23830946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.